Human Performance Club
Learn. Perform. Grow.
HSG Longevity Forum 2026 · Recap
Shaping the next
era of health.
Longer lives are changing everything. Health, work and retirement need a new direction.
At HSG, science, capital and a new generation of founders came together around one mandate: act now.
Explore the highlightsForum highlights
Three moments that matter.
The pressure to change. The gaps to close.
The conviction to build.
“Increasingly
concerning.”
Executive roundtableOur future
cannot wait.AI is changing the first job. Ageing is testing retirement. Our institutions must catch up.Explore the insights
Executive roundtable
The future is arriving.
Our systems are falling behind.
The most sobering conversation of the day connected three pressures that can no longer be addressed in isolation: AI, an ageing population and retirement security.
Potential gap in Zurich’s economic output by 2050 against its previous growth trajectory.
Deloitte & Canton of Zurich · 2026 ↗Workers globally in occupations with some exposure to generative AI. Exposure measures task change, not job losses.
International Labour Organization · 2025 ↗The first rung of the career ladder is under pressure.
Michael Grampp’s provocation was stark: AI could remove the entry roles on which many business-school careers depend. The response was entrepreneurial: build, take ownership and develop judgement that cannot be reduced to a routine task. Founders and intrapreneurs have a head start; care and skilled trades remain essential.
Talent cannot be taken for granted.
Switzerland’s traditional recruiting countries are ageing too. Deloitte’s research suggests migration is unlikely to contribute as much as before. Attracting talent matters, but greater productivity, broader participation and healthier working lives must carry more of the weight.
Retirement needs a broader funding debate.
Marta Ra highlighted the pressure on pensions. The discussion explored sharing AI-driven productivity gains through a dividend approach and pension investment in the AI economy. These are proposals for redesign, with investment risk to assess. The goal remains healthy, independent years and a system able to support them.
“Increasingly concerning.”
An audience member asked the panel to describe the status quo in two words. This was the answer that stayed.
Michael Grampp · Damien Ng · Marta Ra · Sanjeev Kumar
Female health panelHalf the population.
A new health agenda.Women need evidence and care designed around them. Founders have an opening to close the gap.Explore the insights
Female health · FemTech · Longevity
Women’s health deserves
its own market logic.
The panel challenged a persistent assumption: that care designed around a male baseline can simply be extended to women. The scientific gap is also a commercial opening.
More time spent in poor health by women, on average, compared with men.
McKinsey Health Institute & WEF · 2024 ↗Potential annual global GDP gain by 2040 from closing the women’s health gap.
McKinsey Health Institute & WEF · 2024 ↗Precision starts with the right baseline.
Hormonal transitions, disease presentation and the experience of ageing require research and care designed around women across the life course. Sex-specific evidence must inform diagnostics, treatment and prevention.
Demand is ahead of the response.
Unmet needs create space for better diagnostics, accessible care and products built around women’s lives. Healthcare companies need a dedicated strategy, with outcomes and access at its centre.
Founders can set a new standard.
Startups can design around women from day one, without having to retrofit a generic model. The advantage lies in understanding the patient, building the evidence and reaching a clearly defined market.
Fireside chat · Dominik ThorSwitzerland’s
moment to build.Dominik Thor on turning scientific promise into ventures—and more years in good health.Explore the insights
Fireside chat · Dominik Thor
The case for optimism.
After the roundtable’s urgency came a different kind of conviction: progress is possible, and this generation can help create it.
People worldwide aged 60 or over by 2050, according to WHO projections.
World Health Organization ↗Modelled US societal value of slowing ageing enough to add one year of life expectancy.
Scott, Ellison & Sinclair · Nature Aging, 2021 ↗Turn scientific promise into clinical progress.
Dominik Thor brought an optimistic perspective on longevity science and the prospect of progress against diseases such as Alzheimer’s and multiple sclerosis. Major unmet needs create an opening for founders. Demonstrating that an intervention improves patients’ lives is the decisive next step.
Build the institutions that move the field forward.
His journey in founding the Geneva College of Longevity Science returned to a practical question: what expertise, education and entrepreneurial commitment will turn emerging science into better care?
Connect Switzerland’s strengths.
Scientific depth, clinical expertise, capital and international networks make Switzerland an attractive place to build. The opportunity is to connect these assets around prevention and healthy years, then translate them into ventures that reach people.
Dominik Thor · President, Geneva College of Longevity Science
Voices from the forum
What stays. What starts next.
Four perspectives on the day—and the work ahead.
0:42The takeawayWhat the forum made clear.Dr. Anna EratPhysician & longevity specialist
Dr. Anna Erat · Physician & longevity specialist
0:38The takeawayThe mandate we take forward.Jan KesslerPresident, Human Performance Club
Jan Kessler · President, Human Performance Club
0:19The Swiss opportunityWhy Switzerland. Why now.Dominik ThorPresident, GCLS
Dominik Thor · President, GCLS
0:27On the forumWhy this forum matters.Dr. Christoph NabholzFounder & CEO, RiskInsight
Dr. Christoph Nabholz · Founder & CEO, RiskInsight
Nagi Bioscience.
Accelerating the search for healthier ageing.
The EPFL spin-off won the forum’s pitch competition. Its SydLab™ One platform combines microfluidics, small-organism models and automated analysis to study ageing biology and test potential interventions.
0:38Winner’s perspectiveInside the winning venture.Matteo CornagliaCEO & Co-Founder, Nagi Bioscience
Matteo Cornaglia · CEO & Co-Founder, Nagi Bioscience
Startup showcase
Six ventures. One frontier.
From drug discovery to everyday care.
Meet the companies building what comes next.
From organism to insight
Automated small-organism research to study ageing biology and screen potential interventions.
Explore Nagi Bioscience ↗
Rebuilding muscle function
Autologous cell therapy for skeletal muscle regeneration, initially focused on stress urinary incontinence in women.
Explore MUVON Therapeutics ↗
A continuous health picture
Physician-led biomarker diagnostics, wearable data and telemedicine for ongoing preventive care.
Explore AIVONYX ↗
Prevention, personalised
A Zurich longevity clinic combining diagnostics, physician interpretation and individual health planning.
Explore AYUN ↗
The right support, sooner
Matching people with psychologists and psychotherapists for online or in-person support.
Explore ZoneIn ↗
Safer living at home
Ambient AI for fall detection and changes in everyday behaviour, supporting older adults without wearables.
Explore Serai ↗A shared endeavour
Partners & participants.
Forum partners
Speaker organisations
Pitching ventures
Beyond the forum
Stay ahead of
what comes next.
A student-led forum. A shared responsibility to move health forward. Thank you to the speakers, founders, partners and team who made it possible. Continue the conversation with Longevity Intelligence.
Explore Longevity IntelligenceOur Services
We bring together expert-led learning, clinical-grade assessment, and coached training so students, professionals, and athletes can make better decisions about health, performance, and longevity.
Masterclasses
Labs
Training
Lead Partners
